Skip to main content

Screening for Tuberculosis Infection Using Whole-Blood Interferon-γ and Mantoux Testing Among Japanese Healthcare Workers

  • Nobuyuki Harada (a1), Yutsuki Nakajima (a2) (a3), Kazue Higuchi (a1), Yukie Sekiya (a1) (a4), Jim Rothel (a5) and Toru Mori (a1) (a6)...

To examine the hypothesis that results of the QuantiFERON-TB Gold assay (QFT-G), a whole-blood test for detection of tuberculosis infection, are more significantly related to known risk factors for tuberculosis infection in healthcare workers (HCWs) who have received bacille Calmette-Guerin vaccine than are results of the Mantoux tuberculin skin test (TST).


All HCWs (approximately 510) from a 370-bed general hospital in Tokyo where patients with and patients without tuberculosis are treated were invited to participate in the study. All study participants completed a questionnaire about their Mycobacterium tuberculosis infection risk factors as HCWs at the general hospital. They were then tested for LTBI by means of the QFT-G, followed by the TST. Statistical analyses were performed to compare results of each test with M. tuberculosis infection risk factors (age, length of employment in the healthcare industry, history of working with tuberculosis-positive patients in a tuberculosis ward or in the outpatient department of the hospital's tuberculosis clinic for more than 1 year, chest radiograph evidence of healed tuberculosis, history of performing bronchoscope procedures, and job classification), and for TST-positive HCWs, to compare the QFT-G result with the TST induration diameter.


A total of 332 HCWs (95% of whom had been vaccinated with BCG) participated in the study, and 33 had positive QFT-G results, suggesting a prevalence of LTBI of 9.9%. Of 304 HCWs who underwent TST, 283 (93.1%) had an induration diameter of 10 mm or more. Multiple logistic regression analysis revealed that positive QFT-G results were significantly associated with age and with a history of working in a tuberculosis ward or an outpatient department of a tuberculosis clinic. TST results were not correlated with any of the tuberculosis infection risk factors we evaluated.


Positive QFT-G results were closely associated with the presence of risk factors for LTBI in a hospital setting, suggesting that the QFT-G can detect LTBI in a population composed predominately of BCG vaccinees. Because most HCWs worldwide have been vaccinated with BCG, the QFT-G offers a significant improvement over the TST in tuberculosis screening programs and minimizes un-warranted use of tuberculosis prophylaxis.

Corresponding author
Immunology Division, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, 3-1-24, Matsuyama, Kiyose, Tokyo 204-8533, Japan (
Hide All
1.Sepkowitz, KA. Tuberculosis and the health care worker: a historical perspective. Ann Intern Med 1994; 120:7179.
2.Yamauchi, Y. Tuberculosis risk of female nurses based on the Tuberculosis Surveillance Data [in Japanese]. Kekkaku 1999; 74:819821.
3.Barrett-Connor, E. The epidemiology of tuberculosis in physicians. JAMA 1979; 241:3338.
4.Brennen, C, Muder, RR, Muraca, PW. Occult endemic tuberculosis in a chronic care facility. Infect Control Hosp Epidemiol 1988; 9:548552.
5.Goldman, KP. Tuberculosis in hospital doctors. Tubercle 1988; 69:237240.
6.Catanzaro, A. Nosocomial tuberculosis. Am Rev Respir Dis 1982; 125:559562.
7.Ehrenkranz, NJ, Kicklighter, JL. Tuberculosis outbreak in a general hospital: evidence of airborne spread of infection. Ann Intern Med 1972; 77:377382.
8.Haley, CE, McDonald, RC, Rossi, L, Jones, WD Jr, Haley, RW, Luby, JP. Tuberculosis epidemic among hospital personnel. Infect Control Hosp Epidemiol 1989; 10:204210.
9.Kantor, HS, Poblete, R, Pusateri, SL. Nosocomial transmission of tuberculosis from unsuspected disease. Am J Med 1988; 84:833838.
10.Snider, DE Jr, Dooley, SW. Nosocomial tuberculosis in the AIDS era with an emphasis on multidrug-resistant disease. Heart Lung 1993; 22:365369.
11.Jarvis, WR. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis. Res Microbiol 1993; 144:117122.
12.Jereb, JA, Klevens, RM, Privett, TD, et al. Tuberculosis in health care workers at a hospital with an outbreak of MDR Mycobacterium tuberculosis. Arch Intern Med 1995; 155:854859.
13.Edwards, PQ, Edwards, LB. Story of the tuberculin skin test from an epidemiologic viewpoint. Am Rev Respir Dis 1960; 81:147.
14.Judson, FN, Feldman, RA. Mycobacterial skin tests in humans 12 years after infection with Mycobacterium marinum. Am Rev Respir Dis 1974; 109:544547.
15.Snider, DE Jr. Bacille Calmette-Guérin vaccinations and tuberculin skin tests. JAMA 1985; 253:34383439.
16.Huebner, RE, Schein, MF, Bass, JB Jr. The tuberculin skin test. Clin Infect Dis 1993; 17:968975.
17.Andersen, P, Munk, ME, Pollock, JM, Doherty, TM. Specific immune based diagnosis of tuberculosis. Lancet 2000; 356:10991104.
18.Mori, T, Sakatani, M, Yamagishi, F, et al. Specific detection of tuberculosis infection. An interferon-γ-based assay using new antigens. Am J Respir Crit Care Med 2004; 170:5964.
19.Brock, I, Weldingh, K, Lillebaek, T, Follmann, F, Andersen, P. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med 2004; 170:6569.
20.Harada, N, Mori, T, Shishido, S, Higuchi, K, Sekiya, Y. Usefulness of a novel diagnostic method of tuberculosis infection, QuantiFERON-TB-2G, in an outbreak of tuberculosis [in Japanese, with an abstract and tables and figures in English]. Kekkaku 2004; 79:637643.
21.Kang, YA, Lee, HW, Yoon, HI, et al. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005; 293:27562761.
22.Maeda, M, Asami, N, Murohashi, T. Further studies on the potency of purified protein derivatives of tuberculin (PPDs). First report: comparison of the potency of three preparations of PPD [in Japanese]. Kekkaku 1960; 35:563566.
23.Pai, M, Riley, LW, Colford, JM Jr. Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004; 4:761776.
24.Mori, T. Recent trends in tuberculosis, Japan. Emerging Infect Dis 2000; 6:566568.
25.Pai, M, Gokhale, K, Joshi, R, et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 2005; 293:27462755.
26.Karalliedde, S, Katugaha, LP, Uragoda, CG: Tuberculin response of Sri Lankan children after BCG vaccination at birth. Tubercle 1987; 68:3338.
27.Menzies, R, Vissandjee, B, Rocher, I, St Germain, Y. The booster effect in two-step tuberculin testing among young adults in Montreal. Ann Intern Med 1994; 120:190198.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Infection Control & Hospital Epidemiology
  • ISSN: 0899-823X
  • EISSN: 1559-6834
  • URL: /core/journals/infection-control-and-hospital-epidemiology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *


Altmetric attention score